MedTrace Logo

Shared Decision Making for Patients With First-admission Schizophrenia

NCT01869660 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2015-12-30

No results posted yet for this study

Summary

To determine whether shared decision making (SDM) intervention improves patient satisfaction in patients with first-admission schizophrenia compared with usual care.

Conditions

Interventions

BEHAVIORAL

Shared Decision Making

The focus of the SDM is to empower patients to discuss their attitudes and preferences toward treatments.

Sponsors & Collaborators

  • Yokohama City University

    lead OTHER

Principal Investigators

  • Yoshio Hirayasu, PhD · Department of Psychiatry, Yokohama City University School of Medical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2015-04-30
Completion
2015-10-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01869660 on ClinicalTrials.gov